Life Sciences In Action Podcast: Interview with Brad Brown, CEO of ATL Technologies on Tariffs, Manufacturing Overseas, Quality and More
January 17, 2019
The recent tariffs placed on imports have complicated the manufacturing and distribution processes for any life sciences company doing business overseas. In the pilot episode of the Life Scienes in Action Podcast Series, BioUtah president and CEO, Kelvyn Cullimore, interviews Brad Brown, CEO and chairman of ATL Technology, to discuss how the tarriffs have impacted their business. Other topics discussed include:
- Factors influencing overseas manufacturing
- The importance of quality in the manufacturing process
- Vertical integration of the manufacturing process
- What to look for when selecting a medical device manufacturer
- The importance of life sciences companies participating in BioUtah
Recent News
- Steve Pacelli Appointed CEO of Epitel, Inc.
- Sera Prognostics Announces Pricing of $50 Million Public Offering
- The Teva Turnaround: Steering a Company Comeback
- Craig-Hallum Initiates Myriad Genetics Stock with a Buy Rating
- bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid
- EVŌQ Nano Secures Strategic Investment From Global Business Leader & Philanthropist Tony Robbins to Advance Next-Generation Antimicrobial Nanoparticle Technology